These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27196774)

  • 1. Antagonists of IGF:Vitronectin Interactions Inhibit IGF-I-Induced Breast Cancer Cell Functions.
    Kashyap AS; Shooter GK; Shokoohmand A; McGovern J; Sivaramakrishnan M; Croll TI; Cane G; Leavesley DI; Söderberg O; Upton Z; Hollier BG
    Mol Cancer Ther; 2016 Jul; 15(7):1602-13. PubMed ID: 27196774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Insulin-Like Growth Factor-I and Extracellular Matrix Interactions in Melanoma Progression.
    Murekatete B; Shokoohmand A; McGovern J; Mohanty L; Meinert C; Hollier BG; Zippelius A; Upton Z; Kashyap AS
    Sci Rep; 2018 Jan; 8(1):583. PubMed ID: 29330502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-I:vitronectin complex-induced changes in gene expression effect breast cell survival and migration.
    Kashyap AS; Hollier BG; Manton KJ; Satyamoorthy K; Leavesley DI; Upton Z
    Endocrinology; 2011 Apr; 152(4):1388-401. PubMed ID: 21303956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and functional evidence for the interaction of insulin-like growth factors (IGFs) and IGF binding proteins with vitronectin.
    Kricker JA; Towne CL; Firth SM; Herington AC; Upton Z
    Endocrinology; 2003 Jul; 144(7):2807-15. PubMed ID: 12810534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factors (IGF) and IGF-binding proteins bound to vitronectin enhance keratinocyte protein synthesis and migration.
    Hyde C; Hollier B; Anderson A; Harkin D; Upton Z
    J Invest Dermatol; 2004 May; 122(5):1198-206. PubMed ID: 15140223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate-bound insulin-like growth factor (IGF)-I-IGF binding protein-vitronectin-stimulated breast cell migration is enhanced by coactivation of the phosphatidylinositide 3-Kinase/AKT pathway by alphav-integrins and the IGF-I receptor.
    Hollier BG; Kricker JA; Van Lonkhuyzen DR; Leavesley DI; Upton Z
    Endocrinology; 2008 Mar; 149(3):1075-90. PubMed ID: 18079201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic investigations into interactions between IGF-I and IGFBPs and their impact on facilitating cell migration on vitronectin.
    Kricker JA; Hyde CE; Van Lonkhuyzen DR; Hollier BG; Shooter GK; Leavesley DI; Herington AC; Upton Z
    Growth Factors; 2010 Oct; 28(5):359-69. PubMed ID: 20569097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix.
    Arai T; Busby W; Clemmons DR
    Endocrinology; 1996 Nov; 137(11):4571-5. PubMed ID: 8895319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor-II bound to vitronectin enhances MCF-7 breast cancer cell migration.
    Noble A; Towne C; Chopin L; Leavesley D; Upton Z
    Endocrinology; 2003 Jun; 144(6):2417-24. PubMed ID: 12746303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and characterization of IGFBP-mediated endocytosis in the human retinal pigment epithelial cell line ARPE-19.
    Ainscough SL; Feigl B; Malda J; Harkin DG
    Exp Eye Res; 2009 Nov; 89(5):629-37. PubMed ID: 19540231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor binding protein (IGFBP)-3 protease activity secreted by MCF-7 breast cancer cells: inhibition by IGFs does not require IGF-IGFBP interaction.
    Salahifar H; Baxter RC; Martin JL
    Endocrinology; 1997 Apr; 138(4):1683-90. PubMed ID: 9075731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin.
    Lalou C; Lassarre C; Binoux M
    Endocrinology; 1996 Aug; 137(8):3206-12. PubMed ID: 8754741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase-7 facilitates insulin-like growth factor bioavailability through its proteinase activity on insulin-like growth factor binding protein 3.
    Miyamoto S; Yano K; Sugimoto S; Ishii G; Hasebe T; Endoh Y; Kodama K; Goya M; Chiba T; Ochiai A
    Cancer Res; 2004 Jan; 64(2):665-71. PubMed ID: 14744783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitronectin binding to IGF binding protein-5 (IGFBP-5) alters IGFBP-5 modulation of IGF-I actions.
    Nam T; Moralez A; Clemmons D
    Endocrinology; 2002 Jan; 143(1):30-6. PubMed ID: 11751588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface modification by complexes of vitronectin and growth factors for serum-free culture of human osteoblasts.
    Schleicher I; Parker A; Leavesley D; Crawford R; Upton Z; Xiao Y
    Tissue Eng; 2005; 11(11-12):1688-98. PubMed ID: 16411814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysine residues of IGF-I are substrates for transglutaminases and modulate downstream IGF-I signalling.
    Sivaramakrishnan M; Croll TI; Gupta R; Stupar D; Van Lonkhuyzen DR; Upton Z; Shooter GK
    Biochim Biophys Acta; 2013 Dec; 1833(12):3176-3185. PubMed ID: 24036101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitronectin supports migratory responses of corneal epithelial cells to substrate bound IGF-I and HGF, and facilitates serum-free cultivation.
    Ainscough SL; Barnard Z; Upton Z; Harkin DG
    Exp Eye Res; 2006 Dec; 83(6):1505-14. PubMed ID: 17046752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of insulin-like growth factors and their binding proteins in peritoneal dialysate.
    Kale AS; Liu F; Hintz RL; Baker BK; Brewer ED; Lee PD; Durham SK; Powell DR
    Pediatr Nephrol; 1996 Aug; 10(4):467-73. PubMed ID: 8865245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor (IGF)-binding protein-4 proteolytic degradation in bovine, equine, and porcine preovulatory follicles: regulation by IGFs and heparin-binding domain-containing peptides.
    Mazerbourg S; Zapf J; Bar RS; Brigstock DR; Monget P
    Biol Reprod; 2000 Aug; 63(2):390-400. PubMed ID: 10906042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The heparin binding domain of vitronectin is the region that is required to enhance insulin-like growth factor-I signaling.
    Maile LA; Busby WH; Sitko K; Capps BE; Sergent T; Badley-Clarke J; Ling Y; Clemmons DR
    Mol Endocrinol; 2006 Apr; 20(4):881-92. PubMed ID: 16322097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.